| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/12/2009 | CA2693997A1 Viral polymerase inhibitors |
| 02/12/2009 | CA2693495A1 Viral polymerase inhibitors |
| 02/11/2009 | CN101365687A Piperazine compounds with a herbicidal action |
| 02/11/2009 | CN101365680A 3,5-substituted piperidine compounds as renin inhibitors |
| 02/11/2009 | CN101365678A Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 02/11/2009 | CN100460395C Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
| 02/11/2009 | CN100460391C Chemical compounds. |
| 02/10/2009 | US7488824 Process for the production of substituted nicotinic acid esters |
| 02/10/2009 | US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 02/10/2009 | US7488746 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 02/10/2009 | US7488744 Indole-type derivatives as inhibitors of p38 kinase |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/10/2009 | US7488733 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
| 02/10/2009 | CA2451229C Indole derivatives |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009016782A1 Blue photochromic compound, photoreversible color-developing composition, and photofunctional material |
| 02/05/2009 | WO2009016253A2 Cyanomethyl substituted n-acyl tryptamines |
| 02/05/2009 | WO2009016222A1 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives |
| 02/05/2009 | WO2009016219A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives |
| 02/05/2009 | WO2009016218A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 02/05/2009 | WO2009016216A1 Triazole derivatives as scd inhibitors |
| 02/05/2009 | WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 02/05/2009 | WO2008144223A3 Triazolyl aminopyrimidine compounds |
| 02/05/2009 | WO2008125295A3 Novel vanilloid receptor ligands, and their use for the production of pharmaceuticals |
| 02/05/2009 | WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | WO2008028032A4 Therapeutic substituted hydantoins and related compounds |
| 02/05/2009 | US20090036686 Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates |
| 02/05/2009 | US20090036643 Conjugated monomers and polymers and preparation and use thereof |
| 02/05/2009 | US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 02/05/2009 | US20090036463 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine |
| 02/05/2009 | US20090036438 Five-membered heterocycles useful as serine protease inhibitors |
| 02/05/2009 | US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 02/05/2009 | US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/05/2009 | US20090036421 Pyrrole Derivative or Salt Thereof |
| 02/05/2009 | US20090035313 Compounds |
| 02/05/2009 | US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists |
| 02/04/2009 | EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines |
| 02/04/2009 | EP2019827A1 Integrase inhibitors 3 |
| 02/04/2009 | EP2019826A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 02/04/2009 | EP2019825A1 Inhibitors of human immunodeficiency virus replication |
| 02/04/2009 | EP2019820A1 Therapeutic pyrrolidine compounds |
| 02/04/2009 | EP1601653B1 Process for the production of substituted nicotinic acid esters |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101360741A Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 02/04/2009 | CN101360737A 2-amino-5-piperidinylimidazolone compounds and use thereof for (insert beta symbol)-secretase modulation |
| 02/04/2009 | CN101360711A L-phenylalanine derivatives and its application as integrin antagonists |
| 02/04/2009 | CN101357902A Method for preparing N- formyl-2H-4chloroquinoline derivate |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/04/2009 | CN100457728C Tyrosine kinase inhibitors |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/03/2009 | US7485733 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 02/03/2009 | US7485653 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 02/03/2009 | US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 02/03/2009 | US7485641 Substituted 3-amino-pyrrolidino-4-lactams |
| 02/03/2009 | US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
| 02/03/2009 | CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009014100A1 p27 PROTEIN INDUCER |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2009013760A2 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | WO2008152159A3 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 01/29/2009 | WO2008118379A3 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
| 01/29/2009 | US20090030202 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 01/29/2009 | US20090030176 2,3-di(2-thienyl)-5-(4-aminophenyl)-aminoquinoxaline; N-4-aminophenyl-10-aminodibenzo(A,C)phenazine; polyamines obtained by polymerizing the aminoquinoxaline compound; poly{2,3-diphenyl-5-(4-aminophenyl)-aminoquinoxaline; films, solar cell, oraganic light emitter; semiconductor |
| 01/29/2009 | US20090030045 Factor xa inhibitors |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030008 Piperazine derivatives and their use as therapeutic agents |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029971 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
| 01/29/2009 | US20090029969 1-(2,4-dichlorophenyl)-4-methyl-5-(5-(pent-1-enyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; cannabinoid receptor modulator; liver fibrosis, obesity, type II diabetes, atherosclerosis, analgesia, haemorrhagic shock, ischemia, liver cirrhosis, neurodegenerative diseases |
| 01/29/2009 | US20090025781 Novel amino group-containing heterocyclic derivatives and sensitizing dyes for photoelectric conversion containing the heterocyclic derivatives |
| 01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
| 01/29/2009 | CA2693377A1 5-pyridinone substituted indazoles |
| 01/29/2009 | CA2693207A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/28/2009 | EP2018859A1 Arylmethylene substituted N-acyl-beta-amino alcohols |
| 01/28/2009 | EP2018376A1 Benzylamine derivatives as cetp inhibitors |
| 01/28/2009 | EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |